Search

everythinglearnresearchcommunity

for

Search:↓

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Progesterone and allopregnanolone increase glycine release in rat brain cells.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

PRP preparation partially activates platelets, causing varied growth factor release.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

The review found that the way Platelet-Rich Plasma is made varies a lot, which can change the results of medical treatments.

β1 integrin is essential for the survival, growth, and movement of human epithelial progenitor cells.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Higher 3α,5α-THP levels in the brain may reduce depression in pregnant rats.

A simple method was developed to prepare concentrated platelet-rich plasma for use in healing and tissue repair.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Finasteride helps reduce lung inflammation and damage after trauma and infection.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Fish oil increased cell growth and macrophages in the skin but didn't affect COX-2 expression.

Intranasal delivery of gene therapy shows promise for treating ischemic stroke.

5α-reductase inhibitors may help skin flaps survive better by affecting nitric oxide.

Neurosteroids regulate synaptic inhibition in the spinal cord and may help manage spinal pain.

A new model helps study acne and test treatments.

Pulse electric fields can control the release of growth factors and serotonin from platelet-rich plasma, offering a tailored approach to wound healing.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

PRP shows promise in healing and regeneration but needs standardized protocols for consistent results.

Improving artificial vascular grafts requires better materials and surface designs to reduce blood clotting and support blood vessel cell growth.

Platelets can help heal and regenerate tissues, but personalized methods are needed for best results.

Platelet-Rich Fibrin shows promise in medicine and dentistry, but more research is needed to standardize its use.

The new method for making Finasteride is cheaper and safer for large-scale production.